Fabrication and controlled release of electrosprayed ReoPro-loaded metal surface for vascular stent
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Dong Min | - |
dc.contributor.author | Lee, Bong Soo | - |
dc.contributor.author | Kang, Jong Hee | - |
dc.contributor.author | Choi, Jiyeon | - |
dc.contributor.author | Park, Kwideok | - |
dc.contributor.author | Son, Tae-Il | - |
dc.contributor.author | Jeong, Myung Ho | - |
dc.contributor.author | Han, Dong Keun | - |
dc.date.available | 2019-05-29T13:35:26Z | - |
dc.date.issued | 2011-05 | - |
dc.identifier.issn | 1598-5032 | - |
dc.identifier.issn | 2092-7673 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/21572 | - |
dc.description.abstract | Metal stents have been very effective medical devices for coronary artery disease. On the other hand, hyperplasia proliferation of smooth muscle cells and late thrombus formation are the main causes of stent failure. To solve the problem, an anti-platelet/anti-proliferative drug, ReoRro, was used as a target drug for a drug-eluting stent (DES). An emulsion consisting of poly(lactic-co-glycolic acid) (PLGA), ReoRro, and poly(vinyl alcohol) (PVA) was electrosprayed on the stainless steel (SS) specimen. Three specimens were tested: bare-metal SS, PLGA-coated SS, and ReoRro-loaded SS. The surface morphology of polymer/ReoRro layer was smooth and the thickness was approximately 6 mu m. When different formulations of emulsion solutions were examined with various amounts of PVA (1, 5, 10%) or ReoRro (10, 20, 30%), the release profiles were affected significantly by the two factors. More PVA content and higher ReoPro concentration could accelerate the drug release in the given time period. Platelet adhesion and smooth muscle cell (SMC) growth were suppressed significantly in the ReoPro-loaded specimens. This indicates that hydrophilic ReoPro release can be controlled in the hydrophobic PLGA-based release system and the released ReoRro can be effective in suppressing platelet adhesion and SMC overgrowth for vascular stents. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SPRINGER | - |
dc.title | Fabrication and controlled release of electrosprayed ReoPro-loaded metal surface for vascular stent | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s13233-011-0516-6 | - |
dc.identifier.bibliographicCitation | MACROMOLECULAR RESEARCH, v.19, no.5, pp 501 - 506 | - |
dc.identifier.kciid | ART001552969 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000290941800013 | - |
dc.identifier.scopusid | 2-s2.0-79960044734 | - |
dc.citation.endPage | 506 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 501 | - |
dc.citation.title | MACROMOLECULAR RESEARCH | - |
dc.citation.volume | 19 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | stent | - |
dc.subject.keywordAuthor | ReoPro (abciximab) | - |
dc.subject.keywordAuthor | poly(lactic-co-glycolic acid) | - |
dc.subject.keywordAuthor | poly(vinyl alcohol) | - |
dc.subject.keywordAuthor | emulsion | - |
dc.subject.keywordAuthor | drug release | - |
dc.subject.keywordPlus | DRUG-ELUTING STENTS | - |
dc.subject.keywordPlus | THROMBOSIS | - |
dc.subject.keywordPlus | DEVICES | - |
dc.relation.journalResearchArea | Polymer Science | - |
dc.relation.journalWebOfScienceCategory | Polymer Science | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.